References
- Laakso M. Dyslipidemia, morbidity, and mortality in non-insulin-dependent diabetes mellitus: Lipoproteins and coronary heart disease in non-insulin-dependent diabetes mellitus. J Diabetes Complications. 1997; 11:137–41.
- Spijkerman AM, Adriaanse MC, Dekker JM, . Diabetic patients detected by population-based stepwise screening already have a diabetic cardiovascular risk profile. Diabetes Care. 2002; 25:1784–9.
- Borch-Johnsen K. Type 2 diabetes. Prevention of a public disease and its consequences. Ugeskr Laeger 2004; 166:1316–20.
- Glumer C, Jorgensen T, Borch-Johnsen K, Inter99 study. Prevalences of diabetes and impaired glucose regulation in a Danish population: The Inter99 study. Diabetes Care 2003; 26:2335–40.
- Wilson JMG, Jungner G. Principles and practice of screening for disease Geneva. World Health Organization; 1968.
- Faber OK, Sandahl Christiansen J. Ikke-insulinkrævende diabetes – NIDDM (Non-insulin-dependent diabetes mellitus – NIDDM). Copenhagen: Danish College of General Practitioners; 1998.(in Danish)
- Type 2 diabetes i almen. Diagnose og behandling (Type 2 diabetes in general practice. Diagnosis and treatment). Copenhagen: Danish College of General Practitioners; 2002.(in Danish)
- Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: Results of the HOPE study and MICRO-HOPE substudy. Heart Outcomes Prevention Evaluation Study Investigators. Lancet. 2000; 355:253–9.
- Gaede P, Vedel P, Larsen N, Jensen GV, Parving HH, Pedersen O. Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. N Engl J Med 2003; 348:383–93.
- Schrier RW, Estacio RO, Esler A, Mehler P. Effects of aggressive blood pressure control in normotensive type 2 diabetic patients on albuminuria, retinopathy and strokes. Kidney Int 2002; 61:1086–97.
- Lauritzen T, Griffin S, Borch-Johnsen K, Wareham NJ, Wolffenbuttel BH, Rutten G, . The ADDITION study: Proposed trial of the cost-effectiveness of an intensive multifactorial intervention on morbidity and mortality among people with Type 2 diabetes detected by screening. Int J Obes Relat Metab Disord 2000; 24:6–11.
- Christensen JO, Sandbaek A, Lauritzen T, Borch-Johnsen K. Population-based stepwise screening for unrecognised Type 2 diabetes is ineffective in general practice despite reliable algorithms. Diabetologia 2004; 47:1566–73.
- Bjørner JB, . Dansk manual til SF-36. (Danish manual to SF-36). Lif1997.(in Danish)
- Manyemba J, Mangoni AA, Pettingale KW, Jackson SH. Determinants of failure to prescribe target doses of angiotensin-converting enzyme inhibitors for heart failure. Eur J Heart Fail. 2003; 5:693–6.
- Kasje WN, Denig P, Stewart RE, de Graeff PA, Haaijer-Ruskamp FM. Physician, organisational and patient characteristics explaining the use of angiotensin converting enzyme inhibitors in heart failure treatment: A multilevel study. Eur J Clin Pharmacol 2005; 61:145–51.
- Midlov P, Ekesbo R, Johansson L, Gerward S, Persson K, Nerbrand C, . Barriers to adherence to hypertension guidelines among GPs in southern Sweden: A survey. Scand J Prim Health Care 2008; 26:154–9.
- Olivarius Nde F. Diabetes care today: Not everyone should have intensive multipharmacological treatment. Scand J Prim Health Care. 2004; 22:67–70.
- Zoffmann V, Harder I, Kirkevold M. A person-centered communication and reflection model: Sharing decision-making in chronic care. Qual Health Res 2008; 18:670–85.
- Aspinwall LG, Taylor SE. A stitch in time: Self-regulation and proactive coping. Psychol Bull 1997; 121:417–36.
- Holmstrom IM, Rosenqvist U. Misunderstandings about illness and treatment among patients with type 2 diabetes. J Adv Nurs 2005; 49:146–54.